Filing Details
- Accession Number:
- 0001123292-17-000929
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-16 08:50:13
- Reporting Period:
- 2017-05-12
- Filing Date:
- 2017-05-16
- Accepted Time:
- 2017-05-16 08:50:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1621443 | Zynerba Pharmaceuticals Inc. | ZYNE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1327442 | E James Fickenscher | C/O Zynerba Pharmaceuticals, Inc. 80 W. Lancaster Avenue, Suite 300 Devon PA 19355 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-12 | 5,200 | $19.82 | 12,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.63 to $20.25, inclusive. The reporting person undertakes to provide to Zynerba Pharmaceuticals, Inc., any security holder of Zynerba Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
